A roundup of investment news.
Focusing on stocks with the most visible cash flows has been a winning strategy, and this screen can find them.
This screen finds stocks that would make it into Morningstar's Wide-Moat Focus strategy.
Who's in front heading 'round the bend?
Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.
Plus, Vanguard says 401(k) investors stayed the course in 2008, Macquarie Group buys Delaware Investments, more leveraged ETF warnings, and more.
Many funds' fortunes have turned amid these stocks' volatility.
These great businesses are undervalued and run by CEOs that are looking out for the best interests of shareholders.
The drugmaker faces less long-term volatility as the focus shifts to steady businesses.